This company has been marked as potentially delisted and may not be actively trading. Magenta Therapeutics (MGTA) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Magenta Therapeutics Short Interest DataMagenta Therapeutics (MGTA) has a short interest of 383,000 shares, representing 0.81% of the float (the number of shares available for trading by the public). This marks a 33.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 848,835 shares to cover all short positions.Current Short Interest383,000 sharesPrevious Short Interest286,000 sharesChange Vs. Previous Month+33.92%Dollar Volume Sold Short$308.32 thousandShort Interest Ratio1.2 Days to CoverLast Record DateAugust 15, 2023Outstanding Shares60,665,000 sharesFloat Size47,540,000 sharesShort Percent of Float0.81%Today's Trading Volume376,000 sharesAverage Trading Volume848,835 sharesToday's Volume Vs. Average44% Short Selling Magenta Therapeutics? Sign up to receive the latest short interest report for Magenta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMGTA Short Interest Over TimeMGTA Days to Cover Over TimeMGTA Percentage of Float Shorted Over Time Magenta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2023383,000 shares $308.32 thousand +33.9%0.8%1.2 $0.81 7/31/2023286,000 shares $229.37 thousand -27.2%0.6%0.8 $0.80 7/15/2023392,700 shares $301.87 thousand -30.1%0.8%0.8 $0.77 6/30/2023562,100 shares $426.07 thousand +4.9%1.2%1.1 $0.76 6/15/2023535,800 shares $353.63 thousand +8.1%1.1%1.1 $0.66 5/31/2023495,600 shares $320.85 thousand +21.2%1.0%1 $0.65 5/15/2023408,800 shares $286.16 thousand -56.0%0.9%0.8 $0.70 4/30/2023930,000 shares $728.66 thousand -12.3%2.1%1.2 $0.78 4/15/20231,060,000 shares $825.74 thousand -10.9%2.4%0.7 $0.78 3/31/20231,190,000 shares $945.69 thousand -20.7%2.7%0.8 $0.79 Get the Latest News and Ratings for MGTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Magenta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/15/20231,500,000 shares $1.11 million +3.5%3.4%0.8 $0.74 2/28/20231,450,000 shares $1.17 million -5.8%3.2%0.5 $0.81 2/15/20231,540,000 shares $1.29 million +266.0%3.5%0.6 $0.84 1/31/2023420,800 shares $230.14 thousand -31.5%1.1%0.2 $0.55 1/15/2023614,100 shares $329.77 thousand -35.2%1.6%0.4 $0.54 12/30/2022947,700 shares $374.34 thousand -80.8%2.5%0.7 $0.40 12/15/20224,930,000 shares $4.59 million +1,545.5%12.8%4.1 $0.93 11/30/2022299,600 shares $344.54 thousand -6.7%0.8%1.5 $1.15 11/15/2022321,200 shares $481.80 thousand -21.1%0.8%2 $1.50 10/31/2022407,200 shares $525.29 thousand -2.4%1.1%2.6 $1.29 10/15/2022417,200 shares $500.64 thousand -12.7%1.1%2.7 $1.20 9/30/2022478,000 shares $673.98 thousand +4.2%1.3%2.9 $1.41 9/15/2022458,800 shares $798.31 thousand +11.0%1.2%1.9 $1.74 8/31/2022413,500 shares $727.76 thousand -14.5%1.1%1.7 $1.76 8/15/2022483,800 shares $856.33 thousand -6.4%1.3%2 $1.77 7/31/2022516,900 shares $827.04 thousand -11.6%1.4%1.7 $1.60 7/15/2022584,900 shares $1.09 million -32.5%1.6%1.8 $1.86 6/30/2022866,000 shares $1.04 million -50.5%2.4%2.6 $1.20 6/15/20221,750,000 shares $2.10 million +6.1%4.8%5.5 $1.20 5/31/20221,650,000 shares $1.91 million +16.2%4.5%6.1 $1.16 5/15/20221,420,000 shares $1.62 million -2.7%3.9%5.1 $1.14 4/30/20221,460,000 shares $2.09 million +51.7%3.6%6.4 $1.43 4/15/2022962,400 shares $2.16 million -1.8%2.4%3.4 $2.24 3/31/2022980,400 shares $2.84 million -25.7%2.4%3.1 $2.90 3/15/20221,320,000 shares $3.78 million +1.5%3.3%3.9 $2.86 2/28/20221,300,000 shares $4.10 million +33.0%3.2%4 $3.15 2/15/2022977,400 shares $3.12 million +29.6%2.4%3.1 $3.19 1/31/2022754,000 shares $2.47 million -24.5%1.9%2.5 $3.27 1/15/2022998,400 shares $4.47 million -15.4%2.5%3.6 $4.48 12/31/20211,180,000 shares $5.23 million -2.5%2.9%6.6 $4.43The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)It could very well mark the beginning of a new multitrillion-dollar industrial revolution. Up until now, we've imagined robots doing things like cleaning our homes, serving drinks at restaurants, greeting guests in hotel lobbies, stacking shelves in warehouses, and so on. Very soon, there will be a robot that won't do any of that. However, it's impact on the US economy and society will be FAR greater than anything we ever imagined.This little-known company holds nearly 100 patents and trades for around $7 12/15/20211,210,000 shares $6.03 million -9.7%3.0%7.1 $4.98 11/30/20211,340,000 shares $7.54 million +4.7%3.3%7 $5.63 11/15/20211,280,000 shares $9.56 million -5.9%3.2%6.6 $7.47 10/29/20211,360,000 shares $8.70 million -3.6%3.4%6.8 $6.40 10/15/20211,410,000 shares $9.49 million -7.2%3.5%6.4 $6.73 9/30/20211,520,000 shares $11.07 million +18.8%3.8%6.3 $7.28 9/15/20211,280,000 shares $8.49 million -3.0%3.2%4.8 $6.63 8/31/20211,320,000 shares $8.45 million -18.5%3.3%5.5 $6.40 8/13/20211,620,000 shares $10.45 million -1.8%4.2%7 $6.45 7/30/20211,650,000 shares $11.75 million +0.6%4.1%6.5 $7.12 7/15/20211,640,000 shares $14.09 million +1.9%4.0%7.4 $8.59 6/30/20211,610,000 shares $15.75 million +1.3%4.3%7.9 $9.78 6/15/20211,590,000 shares $18.11 million -7.0%5.2%8.5 $11.39 5/28/20211,710,000 shares $21.12 million -8.1%5.5%9.5 $12.35 5/14/20211,860,000 shares $20.37 million -5.1%6.0%7.8 $10.95 4/30/20211,960,000 shares $23.30 million -4.4%6.4%7.3 $11.89 4/15/20212,050,000 shares $22.51 million +3.0%6.6%6.9 $10.98 3/31/20211,990,000 shares $22.75 million +3.1%6.6%6.4 $11.43 3/15/20211,930,000 shares $25.15 million +11.6%6.4%6 $13.03 2/26/20211,730,000 shares $17.91 million +3.6%5.7%5.6 $10.35 2/12/20211,670,000 shares $18.04 million -1.8%5.6%6.7 $10.80 1/29/20211,700,000 shares $14.72 million -8.6%5.8%8.4 $8.66 1/15/20211,860,000 shares $15.92 million -0.5%6.4%9.3 $8.56 12/31/20201,870,000 shares $14.85 million -2.1%6.4%10.6 $7.94 12/15/20201,910,000 shares $13.68 million No Change6.5%11.9 $7.16 11/30/20201,910,000 shares $13.39 million +2.7%6.5%11.1 $7.01 11/15/20201,860,000 shares $12.54 million -0.5%6.4%9.4 $6.74 10/30/20201,870,000 shares $12.59 million +16.2%6.4%8.6 $6.73 10/15/20201,610,000 shares $11.82 million +0.6%5.5%7.6 $7.34 9/30/20201,600,000 shares $10.88 million -1.8%5.5%6.5 $6.80 9/15/20201,630,000 shares $13.04 million +3.8%5.6%4.3 $8.00 8/31/20201,570,000 shares $11.41 million +6.1%5.4%4.4 $7.27 8/14/20201,480,000 shares $10.54 million -4.5%5.1%4.3 $7.12 7/31/20201,550,000 shares $10.88 million +13.1%5.3%4.8 $7.02 7/15/20201,370,000 shares $10.26 million -6.2%5.8%4.3 $7.49 6/30/20201,460,000 shares $10.82 million +43.1%7.2%5 $7.41 6/15/20201,020,000 shares $9.27 million +12.7%4.7%5.4 $9.09 MGTA Short Interest - Frequently Asked Questions What is Magenta Therapeutics' current short interest? Short interest is the volume of Magenta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 383,000 shares of MGTA short. 0.81% of Magenta Therapeutics' shares are currently sold short. Learn More on Magenta Therapeutics' current short interest. What is a good short interest ratio for Magenta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGTA shares currently have a short interest ratio of 1.0. Learn More on Magenta Therapeutics's short interest ratio. What is a good short interest percentage for Magenta Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Magenta Therapeutics' floating shares are currently sold short. Is Magenta Therapeutics' short interest increasing or decreasing? Magenta Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 383,000 shares, an increase of 33.9% from the previous total of 286,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Magenta Therapeutics' float size? Magenta Therapeutics currently has issued a total of 60,665,000 shares. Some of Magenta Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Magenta Therapeutics currently has a public float of 47,540,000 shares. How does Magenta Therapeutics' short interest compare to its competitors? 0.81% of Magenta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Magenta Therapeutics: Kaleido Biosciences, Inc. (0.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Magenta Therapeutics stock? Short selling MGTA is an investing strategy that aims to generate trading profit from Magenta Therapeutics as its price is falling. MGTA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Magenta Therapeutics? A short squeeze for Magenta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGTA, which in turn drives the price of the stock up even further. How often is Magenta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGTA, twice per month. The most recent reporting period available is August, 15 2023. More Short Interest Resources from MarketBeat Related Companies KLDO Short Squeeze APLMW Short Squeeze BCTXW Short Squeeze CDIOW Short Squeeze CEROW Short Squeeze CLNNW Short Squeeze CMRAW Short Squeeze CDTTW Short Squeeze EFTRW Short Squeeze ENGNW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGTA) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Imagine you're driving down I-45 between Dallas and Houston. You come up behind an 18-wheeler, flick your s...Weiss Ratings | SponsoredWall Street Legend: Crash coming in March—details hereBad News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history give...Chaikin Analytics | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredTrump’s treachery A few months ago, I released a list of six companies I believed were going to appreciate under Trump’s second ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Magenta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Magenta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
